| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA594997
Max Phase: Preclinical
Molecular Formula: C30H44N6O8S2
Molecular Weight: 680.85
Molecule Type: Protein
Associated Items:
Representations
Canonical SMILES: CC(C)C[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)CNS(=O)(=O)c1cccc2c(N(C)C)cccc12)C(C)C)C(=O)O
Standard InChI: InChI=1S/C30H44N6O8S2/c1-17(2)13-21(30(41)42)33-25(37)14-31-29(40)27(18(3)4)35-28(39)22(16-45)34-26(38)15-32-46(43,44)24-12-8-9-19-20(24)10-7-11-23(19)36(5)6/h7-12,17-18,21-22,27,32,45H,13-16H2,1-6H3,(H,31,40)(H,33,37)(H,34,38)(H,35,39)(H,41,42)/t21-,22-,27-/m0/s1
Standard InChI Key: QOMZJCAMVYHQBC-BERHBOFZSA-N
Associated Targets(Human)
Protein farnesyltransferase beta subunit 120 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 680.85 | Molecular Weight (Monoisotopic): 680.2662 | AlogP: 0.47 | #Rotatable Bonds: 17 |
| Polar Surface Area: 203.11 | Molecular Species: ACID | HBA: 9 | HBD: 7 |
| #RO5 Violations: 2 | HBA (Lipinski): 14 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
| CX Acidic pKa: 3.71 | CX Basic pKa: 4.68 | CX LogP: -0.28 | CX LogD: -2.42 |
| Aromatic Rings: 2 | Heavy Atoms: 46 | QED Weighted: 0.12 | Np Likeness Score: -0.71 |
References
| 1. Krzysiak AJ, Aditya AV, Hougland JL, Fierke CA, Gibbs RA.. (2010) Synthesis and screening of a CaaL peptide library versus FTase reveals a surprising number of substrates., 20 (2): [PMID:20005705] [10.1016/j.bmcl.2009.11.011] |
Source
Source(1):